Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma

G. Blanchard; E. Guenova

doi:10.1111/bjd.20821

Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma

G. Blanchard
, E. Guenova^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	15-16
Number of pages	2
Journal	British Journal of Dermatology
Volume	186
Issue number	1
DOIs	https://doi.org/10.1111/bjd.20821
Publication status	Published - Jan 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302 Clinical Medicine

Access to Document

10.1111/bjd.20821

Cite this

@article{2275755328d44354a9c1b629434ef6e7,

title = "Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma",

author = "G. Blanchard and E. Guenova",

year = "2022",

month = jan,

doi = "10.1111/bjd.20821",

language = "English",

volume = "186",

pages = "15--16",

journal = "British Journal of Dermatology",

issn = "0007-0963",

number = "1",

}

TY - JOUR

T1 - Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma

AU - Blanchard, G.

AU - Guenova, E.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85122309004

U2 - 10.1111/bjd.20821

DO - 10.1111/bjd.20821

M3 - Article

C2 - 34988981

AN - SCOPUS:85122309004

SN - 0007-0963

VL - 186

SP - 15

EP - 16

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this